Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: Does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials-Reference-Cited by-同舟云学术

Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: Does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials

Published:2013-06 Issue:6 Volume:10 Page:828-835
ISSN:1547-5271
Container-title:Heart Rhythm
language:en
Short-container-title:Heart Rhythm

Author:

Hess Paul L.,Laird Amy,Edwards Rex,Bardy Gust H.,Bigger J. Thomas,Buxton Alfred E.,Moss Arthur J.,Lee Kerry L.,Hall W.J.,Steinman Richard,Dorian Paul,Hallstrom Al,Cappato Riccardo,Kadish Alan H.,Kudenchuk Peter J.,Mark Daniel B.,Al-Khatib Sana M.,Piccini Jonathan P.,Inoue Lurdes Y.T.,Sanders Gillian D.

Publisher

Elsevier BV

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Sudden death due to cardiac arrhythmias;Huikuri;N Engl J Med,2001

2. Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia;Moss;N Engl J Med,1996

3. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction;Moss;N Engl J Med,2002

4. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure;Bardy;N Engl J Med,2005

5. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both;Solomon;N Engl J Med,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating the Time to Benefit for Therapies in Heart Failure with Reduced Ejection Fraction: A Case Study of Sacubitril-Valsartan Using Reconstructed Data from a Randomized Controlled Trial;Drugs & Aging;2022-11-21

2. 2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarction;Russian Journal of Cardiology;2020-12-05

3. Determinants of outcomes following outpatient placement of implantable cardioverter defibrillators in a Medicare Advantage population;Clinical Cardiology;2018-09

4. Extending survival by reducing sudden death with implantable cardioverter-defibrillators: a challenging clinical issue in non-ischaemic and ischaemic cardiomyopathies;European Journal of Heart Failure;2017-11-21

5. New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials;American Heart Journal;2017-09